Literature DB >> 1922006

Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis.

M Castillo1, M Martinez-Cayuela, M F Zafra, E Garcia-Peregrin.   

Abstract

Phenylalanine, phenylpyruvate and phenylacetate produced a considerable inhibition of chick liver mevalonate 5-pyrophosphate decarboxylase while mevalonate kinase and mevalonate 5-phosphate kinase were not significantly affected. Phenolic derivatives of phenylalanine produced a similar inhibition of decarboxylase activity than that found in the presence of phenyl metabolites. The degree of inhibition was progressive with increasing concentrations of inhibitors (1.25-5.00 mM). Simultaneous supplementation of different metabolites in conditions similar to those in experimental phenylketonuria (0.25 mM each) produced a clear inhibition of liver decarboxylase and 3-hydroxy-3-methylglutaryl-CoA reductase. To our knowledge, this is the first report on the in vitro inhibition of both liver regulatory enzymes of cholesterogenesis in phenylketonuria-like conditions. Our results show a lower inhibition of decarboxylase than that of reductase but suggest an important regulatory role of decarboxylase in cholesterol synthesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922006     DOI: 10.1007/bf00230371

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  22 in total

1.  Decarboxylation of mevalonate pyrophosphate is one rate-limiting step in hepatic cholesterol synthesis in suckling and weaned rats.

Authors:  C K Ramachandran; S N Shah
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

2.  Alpha-methylphenylalanine, a new inducer of chronic hyperphenylalaninemia in sucling rats.

Authors:  O Greengard; M S Yoss; J A Del Valle
Journal:  Science       Date:  1976-06-04       Impact factor: 47.728

3.  Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts.

Authors:  D J Shapiro; J L Nordstrom; J J Mitschelen; V W Rodwell; R T Schimke
Journal:  Biochim Biophys Acta       Date:  1974-12-29

4.  Inhibition of sterol synthesis in vitro by metabolites of phenylalanine.

Authors:  S N Shah; N A Peterson; C M McKean
Journal:  Biochim Biophys Acta       Date:  1969

5.  Relationship between changes in free cholesterol and pyrophosphomevalonate decarboxylase activity during myelination.

Authors:  C Marco; D Gonzalez-Pacanowska; A Linares; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1983-06       Impact factor: 3.996

6.  Different thermal behavior of neonatal hepatic and cerebral 3-hydroxy-3-methylglutaryl-CoA reductase.

Authors:  H Ramirez; M J Alejandre; J L Segovia; E Garcia-Peregrin
Journal:  Lipids       Date:  1981-07       Impact factor: 1.880

7.  Inhibition of rat liver mevalonate pyrophosphate decarboxylase and mevalonate phosphate kinase by phenyl and phenolic compounds.

Authors:  C Shama Bhat; T Ramasarma
Journal:  Biochem J       Date:  1979-07-01       Impact factor: 3.857

8.  Secondary regulatory sites in rat liver cholesterol biosynthesis: role of 5-pyrophosphomevalonate decarboxylase.

Authors:  A M Jabalquinto; E Cardemil
Journal:  Lipids       Date:  1980-03       Impact factor: 1.880

9.  Effect of experimental hyperphenylalaninemia induced by dietary phenylalanine plus alpha-methylphenylalanine administration on amino acid concentration in neonatal chick brain, plasma, and liver.

Authors:  M Castillo; M F Zafra; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1988-06       Impact factor: 3.996

10.  Brain phosphorylation and decarboxylation of mevalonic acid in the neonatal chick.

Authors:  D Gonzalez-Pacanowska; J García-Martinez; E García-Peregrín
Journal:  Enzyme       Date:  1981
View more
  8 in total

Review 1.  Oxidative stress in phenylketonuria: future directions.

Authors:  Júlio César Rocha; Maria João Martins
Journal:  J Inherit Metab Dis       Date:  2011-11-25       Impact factor: 4.982

Review 2.  Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations.

Authors:  Patrícia Fernanda Schuck; Fernanda Malgarin; José Henrique Cararo; Fabiola Cardoso; Emilio Luiz Streck; Gustavo Costa Ferreira
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

3.  Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages.

Authors:  K Pahan; F G Sheikh; A M Namboodiri; I Singh
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Phenylbutyrate induces apoptosis and lipid accumulations via a peroxisome proliferator-activated receptor gamma-dependent pathway.

Authors:  Matthew Milkevitch; Nancy J Beardsley; E James Delikatny
Journal:  NMR Biomed       Date:  2010-06       Impact factor: 4.044

5.  The Saccharomyces cerevisiae mevalonate diphosphate decarboxylase is essential for viability, and a single Leu-to-Pro mutation in a conserved sequence leads to thermosensitivity.

Authors:  T Bergès; D Guyonnet; F Karst
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

6.  Simulation of structural and functional properties of mevalonate diphosphate decarboxylase (MVD).

Authors:  Samantha Weerasinghe; Ranil Samantha Dassanayake
Journal:  J Mol Model       Date:  2009-08-04       Impact factor: 1.810

Review 7.  Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders.

Authors:  Karolina M Stepien; Robert Heaton; Scott Rankin; Alex Murphy; James Bentley; Darren Sexton; Iain P Hargreaves
Journal:  J Clin Med       Date:  2017-07-19       Impact factor: 4.241

8.  Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria.

Authors:  Rachna Manek; Yao V Zhang; Patricia Berthelette; Mahmud Hossain; Cathleen S Cornell; Joseph Gans; Gulbenk Anarat-Cappillino; Sarah Geller; Robert Jackson; Dan Yu; Kuldeep Singh; Sue Ryan; Dinesh S Bangari; Ethan Y Xu; Sirkka R M Kyostio-Moore
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.